The Cardiovascular Cell Therapy Research Network , has selected Cytori Therapeutics, Inc. to supply adipose-derived regenerative cells for a clinical trial aimed at evaluating the safety and feasibility of treating patients with Left Ventricular Assist Devices .
http://ift.tt/1tuHzRw
http://ift.tt/1tuHzRw
No comments:
Post a Comment